135 related articles for article (PubMed ID: 38590038)
21. Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series.
Boyarchuk O; Kovalchuk T; Kovalchuk N; Chubata O
Reumatologia; 2020; 58(6):436-443. PubMed ID: 33456087
[TBL] [Abstract][Full Text] [Related]
22. Factors and glucocorticoid usage affecting the prognosis of systemic juvenile idiopathic arthritis.
Paç Kısaarslan A; Özdemir Çiçek S; Şahin N; Başol M; Doğantan Ş; Taşkın SN; Poyrazoğlu MH
Pediatr Int; 2021 Dec; 63(12):1424-1432. PubMed ID: 33760311
[TBL] [Abstract][Full Text] [Related]
23. Proceedings from the 2
Canna SW; Schulert GS; de Jesus A; Pickering A; Brunner H; Gadina M; Levine S; Goldbach-Mansky R; Boutelle J; Sinha R; DeBenedetti F; Grom A;
Pediatr Rheumatol Online J; 2020 Jul; 18(Suppl 1):53. PubMed ID: 32664935
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Different Diagnostic Guidelines for the Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: Single Centre Experience.
Jelušić M; Kronja M; Frković M; Sršen S; Huljev Frković S; Štekić Novački K
Acta Clin Croat; 2018 Jun; 57(2):307-311. PubMed ID: 30431724
[TBL] [Abstract][Full Text] [Related]
25. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
26. Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria.
Silva JR; Brito I
Acta Reumatol Port; 2020; 45(2):150-151. PubMed ID: 32895357
[TBL] [Abstract][Full Text] [Related]
27. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.
Hügle B; Hinze C; Lainka E; Fischer N; Haas JP
Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627
[TBL] [Abstract][Full Text] [Related]
28. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Minoia F; Bovis F; Davì S; Horne A; Fischbach M; Frosch M; Huber A; Jelusic M; Sawhney S; McCurdy DK; Silva CA; Rigante D; Unsal E; Ruperto N; Martini A; Cron RQ; Ravelli A;
Ann Rheum Dis; 2019 Oct; 78(10):1357-1362. PubMed ID: 31296501
[TBL] [Abstract][Full Text] [Related]
29. Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.
Ling XB; Macaubas C; Alexander HC; Wen Q; Chen E; Peng S; Sun Y; Deshpande C; Pan KH; Lin R; Lih CJ; Chang SY; Lee T; Sandborg C; Begovich AB; Cohen SN; Mellins ED
BMC Med; 2012 Oct; 10():125. PubMed ID: 23092393
[TBL] [Abstract][Full Text] [Related]
30. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
31. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives.
Toplak N; Blazina Š; Avčin T
Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038
[TBL] [Abstract][Full Text] [Related]
32. Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease.
Yan X; Tang W; Zhang Z; Zhang Y; Luo C; Tang X
Front Pediatr; 2021; 9():735846. PubMed ID: 34820342
[No Abstract] [Full Text] [Related]
33. Performances of the "MS-score" And "HScore" in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients.
Sag E; Keskin A; Atalay E; Demir S; Cuceoglu MK; Akca UK; Batu ED; Bilginer Y; Ozen S
Rheumatol Int; 2021 Jan; 41(1):87-93. PubMed ID: 33215249
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
Malattia C; Ruperto N; Pederzoli S; Palmisani E; Pistorio A; Wouters C; Dolezalova P; Flato B; Garay S; Giancane G; Wells C; Douglass W; Brunner HI; De Benedetti F; Ravelli A;
Arthritis Res Ther; 2020 Sep; 22(1):211. PubMed ID: 32912276
[TBL] [Abstract][Full Text] [Related]
35. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
Ombrello MJ; Arthur VL; Remmers EF; Hinks A; Tachmazidou I; Grom AA; Foell D; Martini A; Gattorno M; Özen S; Prahalad S; Zeft AS; Bohnsack JF; Ilowite NT; Mellins ED; Russo R; Len C; Hilario MO; Oliveira S; Yeung RS; Rosenberg AM; Wedderburn LR; Anton J; Haas JP; Rosen-Wolff A; Minden K; Tenbrock K; Demirkaya E; Cobb J; Baskin E; Signa S; Shuldiner E; Duerr RH; Achkar JP; Kamboh MI; Kaufman KM; Kottyan LC; Pinto D; Scherer SW; Alarcón-Riquelme ME; Docampo E; Estivill X; Gül A; ; Langefeld CD; Thompson S; Zeggini E; Kastner DL; Woo P; Thomson W
Ann Rheum Dis; 2017 May; 76(5):906-913. PubMed ID: 27927641
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Davidson N; Rangarajan HG; Driest K; Bajwa RPS; Polishchuk V; Abu-Arja RF
Case Rep Rheumatol; 2021; 2021():9323141. PubMed ID: 34123455
[TBL] [Abstract][Full Text] [Related]
37. Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Chellapandian D; Milojevic D
Front Pediatr; 2023; 11():1123104. PubMed ID: 36891226
[TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
39. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Yasin S; Fall N; Brown RA; Henderlight M; Canna SW; Girard-Guyonvarc'h C; Gabay C; Grom AA; Schulert GS
Rheumatology (Oxford); 2020 Feb; 59(2):361-366. PubMed ID: 31326996
[TBL] [Abstract][Full Text] [Related]
40. Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome.
Russo RA; Katsicas MM
J Rheumatol; 2013 Mar; 40(3):329-34. PubMed ID: 23322471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
